Developmental Therapeutics Clinic

发育治疗诊所

• 批准号: 8350210
• 负责人: Giuseppe Giaccone
• 金额: $ 80.13万
• 依托单位: DIVISION OF BASIC SCIENCES - NCI
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8350210
• 关键词: Biological Markers; CCR; Clinic; Clinical; Clinical Research; Clinical Trials; Clinical Trials Design; Development; Developmental Therapeutics Program; Evaluation; Faculty; Malignant Neoplasms; Medical Oncology; Mission; Multicenter Trials; Nursing Research; Patients; Phase; Publications; Research; Therapeutic; Work; cancer diagnosis; cancer therapy; clinical care; drug development; experience; novel; novel diagnostics; oncology; pre-clinical; programs; therapeutic development; working group

The mission of DTC/DTS focuses on developing novel diagnostics and therapies for cancer. These groups are working together to generate biomarkers and therapeutics that span initial research efforts through late-phase clinical trials. Clinicians, research nurses, and support staff from both groups have extensive experience with early-phase combination and single-agent studies and provide outstanding clinical care for patients with advanced malignancies. Over the past four years, DTC/DTS has continued to conduct early-phase clinical trials which have resulted in a number of publications and is coordinating several multicenter trials to open at leading drug development centers across the US.

DTC/DTS的使命专注于开发癌症的新诊断和治疗方法。这些小组正在合作产生生物标记物和疗法，这些生物标记物和疗法跨越了从最初的研究努力到后期临床试验。这两个群体的临床医生、研究护士和支持人员在早期联合和单药研究方面拥有丰富的经验，并为晚期恶性肿瘤患者提供出色的临床护理。在过去的四年里，DTC/DTS继续进行早期临床试验，这些试验已经发表了许多出版物，并正在协调几个多中心试验，以便在美国各地的领先药物开发中心开始。